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Background: Patients with multiple myeloma have a high incidence of AL amyloidosis. Traditional screening modalities including EKG and 
echocardiography have limited value. The aim of this study was to evaluate the role of Brain Natriuretic Peptide (BNP) level in screening 
for cardiac amyloidosis and to evaluate the cardiac MRI features associated with elevated BNP in a large multiple myeloma population at a 
large specialized referral center.
methods: 209 consecutive patients with multiple myeloma who had a baseline BNP level and underwent cardiac MRI between 6/2005 and 
10/2011 were enrolled in this study. Primary endpoint was all cause death. Clinical, EKG, echocardiographic, biomarker and MRI predictors 
for death were analyzed.
results: Mean age of population was 61+/-10 years, 30% of the population had MRI evidence of cardiac involvement. Patients with normal 
BNP (<100pg/ml) have lower wall thickness, lower LV diastolic volumes and left atrial size. 7.1% of patients with a BNP less than 100 had 
MR delayed enhancement pattern suggestive of cardiac amyloidosis of whom two patients had a LV wall thickness less than 1.2 cm.
conclusion:  Though a BNP<100pg/mL is associated with less structural abnormalities by cardiac MRI and confers a better prognosis in 
patients with multiple myeloma, a normal BNP level does not rule out cardiac amyloidosis.
Normal BNP(<100pg/mL)n=70 Elevated BNP(>100pg/mL)n=139 P value
Age 61+/-10 63.4+/-9.7 0.9
Mean BNP 45.3+/-25 895+/-1230
LV ejection fraction by MR 61.2+/-11.2 57.9+/-15.7 0.1
LV end diastolic volume by MR 81.6+/-36.2 94.3+/-46.1 0.04
LA diameter by MR 3.2+/-0.6 3.6+/-0.7 0.001
LV thickness by MR 0.98+/-0.2 1.15+/-0.3 0.0001
MR enhancement suggestive of cardiac 
amylodosis 5(7.1%) 44(31.7%) 0.0001
Mortality 13(18.6%) 60(43.2%) 0.0001
